My virtual meeting with Ian Rees at MHRA—why are gene therapies getting special treatment?
Could it be to clear the way for wall-to-wall mRNA injections? This post is free :)
This is a repost from January 24, 2023
Ian Rees was the Manager for the Inspectorate Strategy and Innovation Unit and MHRA. I had a series of communications with him, and the Senior Regulatory Advisor, Inspection, Enforcement & Standards Division, nearly 18 months ago now.
At the end of the discussions, Ian Rees informed me he was about to retire. This is…